Format

Send to

Choose Destination
See comment in PubMed Commons below
Cytometry B Clin Cytom. 2014 Mar;86(2):98-105. doi: 10.1002/cyto.b.21128. Epub 2013 Oct 8.

CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.

Author information

1
Division of Hematology, Fleury Group, São Paulo, Brazil.

Abstract

BACKGROUND:

Multiparameter flow cytometry is a useful tool for the diagnostic evaluation of mature B-cell neoplasms (MBN). Recently, it has been shown that CD200 may improve the distinction between chronic lymphocytic leukemia (CLL; CD200+) and mantle cell lymphoma (MCL; CD200-), but the role of CD200 expression in atypical CLL and other MBN remains to be established.

METHODS:

To address this issue, we investigated the expression of CD200 in 159 consecutive cases of MBN.

RESULTS:

CD200 was strongly expressed in CLL and was revealed to be an excellent marker to distinguish CLL from MCL, even in cases of atypical CLL. However, lack of CD200 was not an exclusive finding of MCL, being also observed in other MBNs. Furthermore, CD200 was highly expressed in hairy cell leukemia, being useful in the differential diagnosis of lymphomas with villous lymphocytes. Herein, we propose an algorithm to classify CD5+ MBNs based on the expression of CD200, CD11c, heavy chain immunoglobulins, and Matutes score.

CONCLUSIONS:

These results expand the understanding of the CD200 expression in MBNs, giving further support for the inclusion of this marker in the routine investigation by flow cytometry.

KEYWORDS:

CD200; chronic lymphocytic leukemia; flow cytometry; lymphoma; mantle cell lymphoma

PMID:
24243815
DOI:
10.1002/cyto.b.21128
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center